Read the latest insight and see full market statistics for the US...
Read the latest insight and see full market statistics for the US and Canada, for a comprehensive understanding of shifting consumer preferences and how industries are expected to develop in two of the most affluent, innovative and highest demand cou...
Canadian consumers have resumed pre-pandemic lifestyles, with COVID-19 restrictions lifted fully in mid-2022. The return to hectic, out-of-home lifestyles fosters unhealthy diets and irregular eating habits and increases sales for digestive remedies,…
Following the initial high growth phase of the pandemic in 2020, and subsequent slowdown in growth in 2021 as panic-buying receded, dietary supplements has re-entered a period of consistency, and is set to continue to grow at a moderate pace in…
Having witnessed spikes in retail volume sales due to heightened awareness of the importance of health with the onset of the Coronavirus (COVID-19) pandemic, dietary supplements continues to stabilise in 2023. Probiotics supplements are set to…
2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…
Dermatologicals is projected to continue to see positive, if slow, retail value (constant 2023 prices) growth in 2023. However, after posting robust retail volume gains in 2021 and 2022, most categories are projected to see declines in retail volume…
In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…
Cough and cold remedies/products are expected to enjoy demand in 2023. However, the shortages of cough and cold medicines, which provided a consistent disruption in 2022, lingered in 2023. Against this background, manufacturers have struggled to keep…
While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…
In 2023, still relatively high inflation continues to impact prices of essentials, such as groceries, as well as consumer health products, including OTC remedies, vitamins and dietary supplements and sports nutrition. However, consumer demand remains…
There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in…